Advances in the comprehension of diabetes have led to the search for new tools that are aimed at precisely deciphering and targeting ROS-triggered pathways to prevent oxidative damage and its impact to skeletal muscle tissues; accordingly, in this study we investigated the effect of apocynin, an inhibitor of NADPH oxidase [28]. Here, FMO5 is linked to diabetes mellitus.